Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. The company is headquartered in Toronto, Canada.
Metrics to compare | DMED | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipDMEDPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.0x | −5.2x | −0.5x | |
PEG Ratio | −0.12 | 0.04 | 0.00 | |
Price/Book | −7.0x | 0.9x | 2.6x | |
Price / LTM Sales | - | 2.3x | 3.0x | |
Upside (Analyst Target) | - | 239.0% | 53.8% | |
Fair Value Upside | Unlock | −4.0% | 9.6% | Unlock |